Craig R Rush
Overview
Explore the profile of Craig R Rush including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
131
Citations
2291
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rakesh G, Cordero P, Khanal R, Himelhoch S, Rush C
J Affect Disord
. 2024 May;
359:392-393.
PMID: 38815466
No abstract available.
2.
Rakesh G, Cordero P, Khanal R, Himelhoch S, Rush C
J Affect Disord
. 2024 May;
358:432-439.
PMID: 38740269
There is a critical knowledge gap in optimally combining transcranial magnetic stimulation (TMS) and antidepressants to treat patients with major depressive disorder (MDD). TMS is effective in treating MDD in...
3.
Rakesh G, Adams T, Morey R, Alcorn 3rd J, Khanal R, Su A, et al.
Front Psychiatry
. 2024 Mar;
15:1315854.
PMID: 38501083
Background: People living with HIV (PLWHA) smoke at three times the rate of the general population and respond poorly to cessation strategies. Previous studies examined repetitive transcranial magnetic stimulation (rTMS)...
4.
Regnier S, Shellenberg T, Koffarnus M, Cox D, Lile J, Rush C, et al.
Drug Alcohol Depend
. 2023 Nov;
253:111030.
PMID: 38006674
Background: Contingency Management (CM) is being piloted as a treatment for stimulant use disorder in several US states, highlighting the need for treatment optimization. One important goal of optimization is...
5.
Rakesh G, Alcorn 3rd J, Khanal R, Himelhoch S, Rush C
Health Psychol Behav Med
. 2023 Sep;
11(1):2255028.
PMID: 37693107
Background: Special populations like people living with HIV/AIDS (PLWHA) and people with opioid use disorder (OUD) smoke tobacco cigarettes at rates three to four times greater than the general population....
6.
Meadows A, Strickland J, Hyder S, Basconi R, Stull M, Wagner F, et al.
Int J Psychiatry Med
. 2023 Aug;
59(2):218-231.
PMID: 37594029
Objective: Early adversity, such as adverse childhood experiences (ACEs), is a risk factor for the development of substance use disorder (SUD). ACEs are associated with earlier initiation of substance use....
7.
Strickland J, Hatton K, Hays L, Rayapati A, Lile J, Rush C, et al.
Behav Pharmacol
. 2023 Jul;
34(5):275-286.
PMID: 37403694
Commodity purchase tasks provide a useful method for evaluating behavioral economic demand in the human laboratory. Recent research has shown how responding to purchase tasks for blinded drug administration can...
8.
Rakesh G, Naeem S, Elias M, Himelhoch S, Rush C
J ECT
. 2023 Mar;
39(3):e3-e4.
PMID: 36897175
No abstract available.
9.
Regnier S, Stoops W, Lile J, Alcorn 3rd J, Bolin B, Reynolds A, et al.
Pharmacol Biochem Behav
. 2023 Feb;
224:173526.
PMID: 36805862
The FDA has not yet approved a pharmacotherapy for cocaine use disorder despite nearly four decades of research. This study determined the initial efficacy, safety, and tolerability of naltrexone-bupropion combinations...
10.
Stoops W, Strickland J, Hatton K, Hays L, Rayapati A, Lile J, et al.
Pharmacol Biochem Behav
. 2022 Sep;
220:173466.
PMID: 36152876
Preclinical research has sought to understand the role of the orexin system in cocaine addiction given the connection between orexin producing cells in the lateral hypothalamus and brain limbic areas....